During the fireside chat we welcome VolitionRx, ticker symbol, VNRX, that’s Victor, Nancy, Robert, X-ray on the New York Stock Exchange American and their CEO, Cameron Reynolds; and CFO, Scott Powell. Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.

This Fireside Chat was recorded during the Lytham Partners Winter 2021 Investor Conference.